Paper
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Published Dec 31, 2013 · S. Rogovskaya, I. Shabalova, I. Mikheeva
Vaccine
Q1 SJR score
67
Citations
4
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Literature ReviewStudy Snapshot
HPV testing in screening programs may be beneficial in countries with high cervical cancer rates, but current implementation is limited due to pricing, availability, and public awareness.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
HPV vaccination is not fully implemented in Central and Eastern European countries due to high vaccine costs and negative public perception, but screening practices show promising results.
2013·80citations·M. Poljak et al.·Vaccine
Vaccine
Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
Universal HPV vaccination with enhanced screening could significantly reduce the burden of cervical cancer in Central and Eastern Europe and Central Asia.
2013·98citations·F. Bray et al.·Vaccine
Vaccine
Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer
HPV16, 18, and 45 are key factors in cervical cancer, warranting special attention in HPV-based screening programs.
2012·846citations·P. Guan et al.·International Journal of Cancer
International Journal of Cancer
Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia.
High-risk HPV infection prevalence in Tbilisi, Georgia, highlights the need for improved cervical cancer prevention through screening and vaccination.
2011·23citations·T. Alibegashvili et al.·Cancer epidemiology
Cancer epidemiology
Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3
HPV co-factors display unique profiles in progression to CIN1, CIN2, and CIN3, suggesting genuine biological differences between the three CIN grades.
2011·11citations·K. Syrjänen et al.·International Journal of STD & AIDS
International Journal of STD & AIDS
Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
The HPV test is a useful screening tool for detecting high-grade cervical intraepithelial neoplasia in unvaccinated Russian women over 30 years of age.
2011·29citations·E. Shipitsyna et al.·Cancer epidemiology
Cancer epidemiology
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Cancer incidence and mortality rates are highest in less developed regions, with lung, breast, and colorectal cancers being the most common diagnoses and deaths.
2010·21700citations·J. Ferlay et al.·International Journal of Cancer
International Journal of Cancer
Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe
The Pap test is a highly specific screening option in populations with medium-range cervical cancer prevalence, while combined HPV testing may slightly improve positive predictive values in women 35 years of age with LSIL, but at a high incremental cost.
2010·11citations·L. Sarian et al.·Journal of Medical Screening
Journal of Medical Screening
Citations
Prospects for Comprehensive Screening and Treatment of Cervical Cancer
Comprehensive cervical cancer screening and treatment requires concerted efforts, particularly in developing countries, to address current challenges and reduce incidence and mortality.
2024·1citation·S. A. Begliarzade et al.·Creative surgery and oncology
Creative surgery and oncology
High-risk human papillomaviruses l1 gene isolates identified in Western Kazakhstan
High-risk human papillomaviruses, including HPV16 and HPV53, are present in Western Kazakhstan, with various geographic pathways contributing to its spread.
2024·0citations·Saule K. Balmagambetova et al.·Journal of Clinical Medicine of Kazakhstan
Journal of Clinical Medicine of Kazakhstan
Health improvement of the elderly in five Central Asian countries during COVID-19 based on difference game
During COVID-19, providing home medical services or "green channel" services for the elderly in Central Asian countries led to greater social benefits for both the elderly and government, but decreased government credibility.
2023·0citations·Yuntao Bai et al.·PLOS ONE
PLOS ONE
The relationship between individuals’ knowledge about human papilloma virus, beliefs, and vaccination status: analysis with data mining
Increased knowledge about human papillomavirus increases individuals' perceived susceptibility and severity, potentially impacting their HPV health beliefs.
2023·3citations·M. Yıldız et al.·Journal of Public Health
Journal of Public Health
Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey
Parallel screening systems for breast and cervical cancers are widespread across Eastern Europe and Central Asia, suggesting a need for population-based programs with quality assurance and control.
2023·5citations·A. Znaor et al.·Journal of Cancer Policy
Journal of Cancer Policy